510 related articles for article (PubMed ID: 17893529)
1. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops.
Ozcan AA; Ersoz TR; Dulger E
Cornea; 2007 Oct; 26(9):1035-8. PubMed ID: 17893529
[TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.
Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S
Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182
[TBL] [Abstract][Full Text] [Related]
3. Topical cyclosporin A in the management of vernal keratoconjunctivitis.
Gupta V; Sahu PK
Eye (Lond); 2001 Feb; 15(Pt 1):39-41. PubMed ID: 11318292
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.
Akpek EK; Dart JK; Watson S; Christen W; Dursun D; Yoo S; O'Brien TP; Schein OD; Gottsch JD
Ophthalmology; 2004 Mar; 111(3):476-82. PubMed ID: 15019322
[TBL] [Abstract][Full Text] [Related]
5. [Cyclosporin A 2% eyedrops in therapy of atopic and vernal keratoconjunctivitis].
Tomida I; Schlote T; Bräuning J; Heide PE; Zierhut M
Ophthalmologe; 2002 Oct; 99(10):761-7. PubMed ID: 12376851
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.
Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651
[TBL] [Abstract][Full Text] [Related]
7. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis.
Doan S; Gabison E; Gatinel D; Duong MH; Abitbol O; Hoang-Xuan T
Am J Ophthalmol; 2006 Jan; 141(1):62-66. PubMed ID: 16386977
[TBL] [Abstract][Full Text] [Related]
8. Topical cyclosporin A 2% in the treatment of vernal keratoconjunctivitis.
Mendicute J; Aranzasti C; Eder F; Ostolaza JI; Salaberria M
Eye (Lond); 1997; 11 ( Pt 1)():75-8. PubMed ID: 9246280
[TBL] [Abstract][Full Text] [Related]
9. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children.
Tesse R; Spadavecchia L; Fanelli P; Rizzo G; Procoli U; Brunetti L; Cardinale F; Miniello VL; Bellizzi M; Armenio L
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):330-5. PubMed ID: 19840298
[TBL] [Abstract][Full Text] [Related]
11. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis.
Tzu JH; Utine CA; Stern ME; Akpek EK
Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children.
Keklikci U; Soker SI; Sakalar YB; Unlu K; Ozekinci S; Tunik S
Jpn J Ophthalmol; 2008; 52(5):357-362. PubMed ID: 18991035
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic use of topical cyclosporine.
Kaan G; Ozden O
Ann Ophthalmol; 1993 May; 25(5):182-6. PubMed ID: 8517589
[TBL] [Abstract][Full Text] [Related]
15. Systemic tacrolimus in the treatment of severe atopic keratoconjunctivitis.
Stumpf T; Luqmani N; Sumich P; Cook S; Tole D
Cornea; 2006 Dec; 25(10):1147-9. PubMed ID: 17172887
[TBL] [Abstract][Full Text] [Related]
16. Topical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitis.
Kosrirukvongs P; Luengchaichawange C
J Med Assoc Thai; 2004 Feb; 87(2):190-7. PubMed ID: 15061303
[TBL] [Abstract][Full Text] [Related]
17. Topical cyclosporin A in severe allergic conjunctivitis.
Bellini LP; Bulla MC; Brum GS
Cornea; 2008 Jun; 27(5):625; author reply 625. PubMed ID: 18520520
[No Abstract] [Full Text] [Related]
18. Topical cyclosporine in the management of shield ulcers.
Cetinkaya A; Akova YA; Dursun D; Pelit A
Cornea; 2004 Mar; 23(2):194-200. PubMed ID: 15075890
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.
Brignole F; Pisella PJ; De Saint Jean M; Goldschild M; Goguel A; Baudouin C
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):90-5. PubMed ID: 11133852
[TBL] [Abstract][Full Text] [Related]
20. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial.
De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P
Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
